Nocturnal lagophthalmos: an overview and classification (Q28238074)

Symptomatic nocturnal lagophthalmos.

Europe PubMed Central

title

Nocturnal lagophthalmos: an overview and classification (English)

0 references

author name string

Robert L Latkany

series ordinal

1

0 references

Barbara Lock

series ordinal

2

0 references

Mark Speaker

series ordinal

3

0 references

language of work or name

English

0 references

publication date

January 2006

0 references

published in

The Ocular Surface

0 references

volume

4

0 references

issue

1

0 references

page(s)

44-53

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Physiologic Lagophthalmos

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Lagophthalmos during sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Sleep with half-open eyes, physiologic lagophthalmus.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Nocturnal lagophthalmos and recurrent erosion

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Corneal exposure during sleep (nocturnal lagophthalmos)

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Recurrent erosion of the cornea

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

The lack of association between signs and symptoms in patients with dry eye disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Ocular surface disease in intensive care unit patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Dry eye after refractive surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Bilateral lagophthalmos. An unusual presentation of metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

New insights into the diagnosis and treatment of dry eye

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

The contribution of meibomian disease to dry eye

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Lagophthalmos in enophthalmic eyes

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Lagophthalmos: an unusual manifestation of oculomotor nerve aberrant regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

SOME OBSERVATIONS ON THE ACTS OF CLOSING AND OPENING THE EYES

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Blinking and the Mechanics of the Lacrimal Drainage System

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

1 reference

7 January 2021

Use of isobutyl cyanoacrylate tissue adhesive to stabilize external eyelid weights in temporary treatment of facial palsies

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Treatment of facial palsies with external eyelid weights

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

[Protective ptosis by botulinum A toxin injection in corneal affectations]

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Effect of botulinum toxin A on facial wrinkle lines in Koreans

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Dry eyes and superficial punctate keratitis: a complication of treatment of glabelar dynamic rhytides with botulinum exotoxin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Eyelid reanimation for the treatment of paralytic lagophthalmos: historical perspectives and current applications of the gold weight implant

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Long-term outcome of gold eyelid weights in patients with facial nerve palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

[Pretarsal platinum-iridium implants for therapy of lagophthalmos in facial paralysis. Preliminary results]

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

[Lidloading and intraocular pressure].

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

1 reference

7 January 2021

Effect of an oil and water emulsion on tear evaporation rate

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Efficacy and safety of infrared warming of the eyelids

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Disposable eyelid-warming device for the treatment of meibomian gland dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Meibomian gland triglyceride fatty acid differences in chronic blepharitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Oral tetracyclines for ocular rosacea: an evidence-based review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Nutrient intake in women with primary and secondary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Dry eyes and video display terminals

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

And so to sleep: hypnotherapy for lagophthalmos.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Minocycline-induced autoimmune syndromes: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Minocycline-induced scleral, dental, and dermal pigmentation.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Minocycline-induced scleral pigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Minocycline-induced ocular pigmentation

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

Punctal plugs in the management of dry eyes

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021

The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1542-0124%2812%2970263-X

7 January 2021